Insperity
NSP
48.23
+1.81
+3.90%
Insperity
US · NSP
#2868 by market cap
Listed 1970
48.23
+1.81
+3.90%
Live - 5344 symbols - heartbeat 304s ago
· 2026-10-08 07:56
Pre-market
48.00
-0.48%
After-hours
48.23
0.00%
- Market cap
- 1.84B
- P/E (TTM)i
- -109.61
- P/Bi
- 30.20
- EPSi
- -0.19
- Div yieldi
- 4.98%
- 52W posi
- 81%
Reader sentiment
Are you bullish or bearish on NSP?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.05, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +3.51% YoY
Margins
- Gross margin
- 13.21%
- Operating margin
- -0.15%
- Net margin
- -0.10%
Key ratios & quality
- Altman Z-Scorei
- 4.05
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.83B | 4.31B | 4.29B | 4.97B | 5.94B | 6.49B | 6.58B | 6.81B |
| Gross profit | 681.91M | 732.93M | 806.85M | 820.10M | 1.01B | 1.04B | 1.05B | 900.00M |
| Selling & admin expenses | 451.07M | 486.16M | 548.14M | 573.30M | 674.00M | 728.00M | 844.00M | 820.00M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 179.04M | 186.63M | 194.69M | 173.33M | 250.00M | 219.00M | 117.00M | -10.00M |
| Pretax profit | 182.36M | 189.64M | 189.27M | 168.32M | 245.00M | 225.00M | 126.00M | -4.00M |
| Tax | 46.95M | 38.54M | 51.03M | 44.24M | 66.00M | 54.00M | 35.00M | 3.00M |
| Net profit | 135.41M | 151.10M | 138.24M | 124.08M | 179.00M | 171.00M | 91.00M | -7.00M |
| Basic EPS | 3 | 4 | 4 | 3 | 5 | 5 | 2 | 0 |
| Diluted EPS | 3.22 | 3.70 | 3.54 | 3.18 | 4.64 | 4.47 | 2.42 | -0.19 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.86B | 1.66B | 1.62B | 1.67B | 1.90B | 1.69B |
| Gross profit | 310.00M | 223.00M | 195.00M | 172.00M | 302.00M | 217.00M |
| Selling & admin expenses | 220.00M | 209.00M | 196.00M | 195.00M | 219.00M | 191.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 68.00M | -7.00M | -25.00M | -46.00M | 62.00M | 6.00M |
| Pretax profit | 72.00M | -6.00M | -24.00M | -46.00M | 63.00M | 5.00M |
| Tax | 21.00M | -1.00M | -4.00M | -13.00M | 30.00M | 1.00M |
| Net profit | 51.00M | -5.00M | -20.00M | -33.00M | 33.00M | 4.00M |
| Basic EPS | 1 | 0 | -1 | -1 | 1 | 0 |
| Diluted EPS | 1.35 | -0.14 | -0.53 | -0.88 | 0.88 | 0.10 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 866.54M | 974.75M | 1.08B | 1.24B | 1.51B | 1.60B | 2.09B | 1.72B |
| Cash & ST investments | 387.55M | 402.07M | 589.38M | 607.60M | 765.90M | 709.00M | 1.06B | 660.00M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 1.19B | 1.39B | 1.58B | 1.75B | 2.04B | 2.12B | 2.60B | 2.20B |
| Total current liabilities | 772.33M | 869.05M | 904.92M | 1.13B | 1.35B | 1.44B | 1.93B | 1.62B |
| Short-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Long-term debt | 144.40M | 269.40M | 369.40M | 369.40M | 369.40M | 369.00M | 369.00M | 369.00M |
| Total liabilities | 1,114,140,000.00 | 1,390,917,000.00 | 1,540,144,000.00 | 1,754,859,000.00 | 1,957,986,000.00 | 2,026,000,000.00 | 2,500,000,000.00 | 2,157,000,000.00 |
| Total equity | 77.68M | 4.08M | 44.13M | -1.77M | 81.28M | 94.00M | 97.00M | 46.00M |
| Retained earnings | 397.95M | 499.47M | 575.03M | 553.59M | 655.19M | 739.00M | 738.00M | 638.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.65B | 1.52B | 1.55B | 1.72B | 1.73B | 1.77B |
| Cash & ST investments | 568.00M | 456.00M | 440.00M | 660.00M | 555.00M | 619.00M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 2.14B | 2.02B | 2.01B | 2.20B | 2.20B | 2.23B |
| Total current liabilities | 1.47B | 1.36B | 1.38B | 1.62B | 1.59B | 1.59B |
| Short-term debt | -- | -- | -- | -- | -- | -- |
| Long-term debt | 369.00M | 369.00M | 369.00M | 369.00M | 369.00M | 419.00M |
| Total liabilities | 2,024,000,000.00 | 1,906,000,000.00 | 1,925,000,000.00 | 2,157,000,000.00 | 2,129,000,000.00 | 2,173,000,000.00 |
| Total equity | 119.00M | 112.00M | 87.00M | 46.00M | 67.00M | 61.00M |
| Retained earnings | 764.00M | 736.00M | 694.00M | 638.00M | 648.00M | 629.00M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 184.48M | 205.15M | 346.35M | 260.16M | 347.00M | 198.00M | 520.00M | -278.00M |
| Depreciation & amortization | 22.84M | 28.72M | 31.19M | 38.55M | 41.00M | 43.00M | 44.00M | 45.00M |
| Free cash flow | 149.15M | 148.85M | 248.19M | 227.30M | 317.00M | 158.00M | 482.00M | -309.00M |
| Dividends paid | -33.41M | -48.62M | -61.87M | -144.18M | -77.00M | -84.00M | -89.00M | -90.00M |
| Stock buybacks / issuance | -113.33M | -203.04M | -99.42M | -69.73M | -73.00M | -131.00M | -63.00M | -19.00M |
| Ending cash balance | 535.47M | 592.55M | 786.70M | 807.77M | 1.01B | 1.04B | 1.34B | 945.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -443.00M | -79.00M | -11.00M | 255.00M | -67.00M | 48.00M |
| Depreciation & amortization | 11.00M | 11.00M | 11.00M | 12.00M | 11.00M | 10.00M |
| Free cash flow | -449.00M | -86.00M | -20.00M | 246.00M | -73.00M | 41.00M |
| Dividends paid | -23.00M | -22.00M | -23.00M | -22.00M | -23.00M | -23.00M |
| Stock buybacks / issuance | -19.00M | 0 | 0 | 0 | -4.00M | 0 |
| Ending cash balance | 846.00M | 733.00M | 688.00M | 945.00M | 826.00M | 910.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 185.47 | 365.34 | 570.22 | 584.87 | 451.19 | 195.98 | 95.48 | -9.79 |
| ROA %i | 11.84 | 11.55 | 9.23 | 7.42 | 9.46 | 8.24 | 3.86 | -0.29 |
| ROIC %i | 66.74 | 53.01 | 34.91 | 28.05 | 38.99 | 32.41 | 16.06 | -2.32 |
| 5-year avg ROE %i | 80.66 | 151.45 | 261.42 | 367.32 | 431.44 | 433.37 | 379.36 | 263.36 |
| EBIT margin %i | 4.89 | 4.57 | 4.60 | 3.53 | 4.37 | 3.89 | 2.34 | 0.29 |
| FCF / sales %i | 3.90 | 3.45 | 5.79 | 4.57 | 5.34 | 2.44 | 7.32 | -- |
| Current ratioi | 1.12 | 1.12 | 1.19 | 1.10 | 1.12 | 1.11 | 1.08 | 1.06 |
| Quick ratioi | 1.02 | 1.00 | 1.09 | 1.00 | 1.03 | 0.98 | 0.98 | 0.94 |
| Debt / assetsi | 12.12 | 23.53 | 27.37 | 24.73 | 20.84 | 20.14 | 16.75 | 19.75 |
| LT debt / equityi | 185.90 | 8,047.63 | 982.71 | -- | 522.90 | 454.26 | 448.45 | 945.65 |
| Interest coveragei | 40.07 | 25.80 | 24.61 | 23.57 | 18.27 | 9.29 | 5.50 | 0.83 |
| Revenue CAGR (3Y) %i | 13.72 | 13.62 | 9.11 | 9.11 | 11.24 | 14.80 | 9.79 | 4.68 |
| Net income CAGR (3Y) %i | 50.92 | 31.80 | 17.88 | -2.87 | 5.81 | 7.35 | -9.82 | -- |
| FCF CAGR (3Y) %i | 46.70 | 10.15 | 11.33 | 15.08 | 28.66 | -13.98 | 28.47 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 48.65 | 31.50 | 16.04 | -9.79 | -26.88 | -18.50 |
| ROA %i | 2.95 | 1.95 | 0.86 | -0.29 | -1.15 | -0.75 |
| ROIC %i | 9.96 | 6.03 | 1.97 | -2.32 | -5.10 | -3.05 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 1.72 | 1.22 | 0.80 | 0.29 | 0.16 | 0.32 |
| FCF / sales %i | 0.11 | -- | 0.75 | -- | 0.98 | 2.82 |
| Current ratioi | 1.13 | 1.12 | 1.12 | 1.06 | 1.09 | 1.11 |
| Quick ratioi | 0.96 | 0.97 | 0.99 | 0.94 | 0.92 | 0.96 |
| Debt / assetsi | 20.35 | 21.61 | 21.67 | 19.75 | 19.58 | 21.40 |
| LT debt / equityi | 366.39 | 389.29 | 501.15 | 945.65 | 641.79 | 783.61 |
| Interest coveragei | 4.22 | 3.15 | 2.16 | 0.83 | 0.46 | 0.92 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Human Resources (HR) Solutions100.00%
Quote time 2026-10-08 07:56:39 · For reference only, not investment advice and not tailored to your situation.